Dok Hyun Yoon

Also affiliated with Daewoo Electronics (South Korea), Asan Medical Center, University of Ulsan, Seoul Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “823 | A PHASE IA/IB OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMIC OF UBX‐303061 IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES”.

823 | A PHASE IA/IB OPEN‐LABEL STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMIC OF UBX‐303061 IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES

Hematological Oncology(2025)10.1002/hon.70096_823

N/A

0DataRank · unranked

0 citations

Dok Hyun Yoon, Ki‐Seong Eom, Yeon Soo Jeon, Sukhyang Lee, J. Ryu +4 more

Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma

The Korean Journal of Medicine(2019)10.3904/kjm.2019.94.2.152

N/A

0DataRank · unranked

0 citations

Dok Hyun Yoon, Heejung Chae